Glimepiride primarily manages blood sugar in type 2 diabetes but has limited direct effects on reducing macrovascular complications like heart disease or stroke.

Although Glimepiride helps control blood sugar, there is no significant evidence that it directly lowers the risk of macrovascular complications in diabetes.

Glimepiride is used for blood sugar control in type 2 diabetes; it does not directly impact the occurrence of macrovascular complications such as strokes or heart events.